Toxic Reactive Oxygen Species Enhanced Synergistic Combination Therapy by Self-Assembled Metal-Phenolic Network Nanoparticles

Abstract

Engineering functional nanomaterials with high therapeutic efficacy and minimum side effects has increasingly become a promising strategy for cancer treatment. Herein, a reactive oxygen species (ROS) enhanced combination chemotherapy platform is designed via a biocompatible metal-polyphenol networks self-assembly process by encapsulating doxorubicin (DOX) and platinum prodrugs in nanoparticles. Both DOX and platinum drugs can activate nicotinamide adenine dinucleotide phosphate oxidases, generating superoxide radicals (O₂^•−). The superoxide dismutase-like activity of polyphenols can catalyze H₂O₂ generation from O₂^•−. Finally, the highly toxic HO^• free radicals are generated by a Fenton reaction. The ROS HO^• can synergize the chemotherapy by a cascade of bioreactions. Positron emission tomography imaging of ⁸⁹Zr-labeled as-prepared DOX@Pt prodrug Fe³⁺ nanoparticles (DPPF NPs) shows prolonged blood circulation and high tumor accumulation. Furthermore, the DPPF NPs can effectively inhibit tumor growth and reduce the side effects of anticancer drugs. This study establishes a novel ROS promoted synergistic nanomedicine platform for cancer therapy.

A self-assembled reactive oxygen species (ROS) promoting combination drug delivery platform based on metal-polyphenol networks is designed by encapsulating doxorubicin and platinum prodrugs in nanoparticles. The nanoparticles exhibit excellent tumor inhibition and long survival time due to the high tumor accumulation and ROS enhanced chemotherapy by cascade bioreactions in cancer cells.

http://ift.tt/2qFuopR